SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy ($MULN) is trending as a speculative Solana-based meme coin that has polarized the community, with some investors betting on parabolic recovery plays while many others label it a continuation of the negative sentiment surrounding the original Mullen Automotive stock. Participants are actively debating the token's extreme volatility and its status as a high-risk "pump and dump" project versus a community-driven attempt to recover historical investment losses.

XDC Network is an enterprise-ready hybrid Blockchain technology company optimized for international trade and finance. The XDC Network is powered by the native coin called XDC. The XDC protocol is architected to support smart contracts, 2000TPS, 2seconds transaction time, KYC to Masternodes (Validator Nodes). The XDC Chain (XinFin Digital Contract) uses XinFin Delegated Proof of Stake (XDPoS), with the intending to create a ‘highly-scalable, secure, permission, and commercial grade’ blockchain network. XinFin mainnet token XDC and also creates an opportunity to utilize the XinFin’s real-world use-cases such as TradeFinex.org, helps small and medium businesses or institutions originate their own financial requirements in a digital, fully structured manner so that they can distribute it to the bank or non-bank funders themselves using a common distribution standard.

XinFin Network

XinFin Network (XDC) is currently trending as a focus for utility-focused investors who are heavily discussing its potential role in global trade finance, ISO 20022 compliance, and institutional adoption. The community is actively debating the coin's long-term value, with many participants using current price consolidation to accumulate positions while comparing its growth potential against other major infrastructure-oriented tokens.

Linea is the Layer 2 built from first principles to strengthen Ethereum and the entire ETH economy. Every aspect of its design—from its productive ETH burn mechanics, and capital efficient native yield, to its underlying Ethereum-equivalent zk tech—amplifies the value and utility of Ethereum Mainnet. All of this is backed by the largest ecosystem fund in the space, managed by the most trusted Ethereum builders. With institutional-grade infrastructure, and deep integration across DeFi, Linea is the best chain for ETH capital, where every transaction and every block strengthens Ethereum. Linea is where Ethereum wins.

Linea

The Linea community is intensely debating the project's potential integration with SWIFT, with many investors viewing the development as a major institutional catalyst and a strategic play within the Ethereum ecosystem. While some are optimistic about long-term value and the project's institutional backing, others express significant frustration over volatile price action, token unlock concerns, and communication gaps from the team.

USDX is the crypto-backed native stablecoin of the Kava DeFi hub.

USDX Stablecoin

The USDX stablecoin is currently at the center of investor focus as the market navigates the fallout from high-profile DeFi platform collapses and ongoing regulatory efforts by stablecoin issuers to integrate more deeply into the traditional U.S. financial system. Community members are actively analyzing the coin's stability and risk profile, while market participants weigh broader sentiment regarding stablecoin reliability amid recent volatility.

Maul Coin

Maul Coin is trending as community members rally behind what they describe as an organic, developer-backed project while pushing for increased social media engagement and chart listings. Discussions are heavily focused on the coin's rapid growth and the potential for a parabolic breakout as the community aims to reach higher market capitalization milestones.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is gaining momentum following its strategic acquisition of StereoLabs, a move that establishes the company as a unified sensing and perception platform for Physical AI by integrating lidar with high-performance 3D vision. The community is actively discussing the stock's improved path to profitability and strengthened competitive position in the robotics, industrial, and smart infrastructure sectors.

CSX Corp. engages in the provision of rail-based freight transportation services. Its services include rail service, the transport of intermodal containers and trailers, rail-to-truck transfers, and bulk commodity operations. It operates through Rail and Trucking segments. The Rail segment provides rail-based transportation services including traditional rail service and the transport of intermodal containers. The Trucking segment relates to quality carriers. The company was founded in 1827 and is headquartered in Jacksonville, FL.

CSX Corp.

CSX Corp. is currently trending amid increased volatility following a mixed earnings report and the disclosure of a subpoena from the SEC related to previous accounting restatements and performance metrics. Investors are actively debating the company's long-term outlook, weighing potential M&A speculation, dividend hikes, and fleet modernization efforts against concerns over weak coal demand, operational disruptions, and a competitive landscape that has industry participants closely watching for further consolidation.

Direxion Shares ETF Trust - Direxion Daily S&P 500 Bear 3X ETF

Direxion Daily S&P 500 Bear 3X Shares

SPXS is trending as investors debate the sustainability of the current S&P 500 rally, with many traders accumulating positions in the inverse ETF as a hedge against potential volatility and technical resistance. The community is actively discussing market complacency, the impact of high-interest rates, and concerns that major indices are disconnected from broader economic data, leading to a divide between those anticipating a major correction and those betting on continued momentum.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing intense volatility and heavy retail interest, as the community debates whether the stock is a prime candidate for a short squeeze or a value trap due to its high debt and challenging earnings outlook. Market participants are intensely focused on the divergence between the stock's significant short interest and its recent performance, with many weighing the impact of potential fleet rotation strategies and macroeconomic pressures against bearish analyst downgrades.

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

MediWound Ltd

MediWound is trending due to a major government contract award for its burn treatment, NexoBrid, sparking intense debate among investors about the company's long-term valuation and potential for acquisition. While some community members highlight the strategic significance of the contract and institutional backing, others are focused on technical price patterns, expressing skepticism about the stock's ability to sustain gains amidst a broader market correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Biotech Stocks To Follow Today - April 4th

Vertex Pharmaceuticals, Danaher, United Therapeutics, argenex, Moderna, Cocrystal Pharma, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Element Squared LLC Acquires New Position in United Therapeutics Corporation $UTHR

Element Squared LLC bought a new position in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities...

Biotech Stocks To Watch Now - April 3rd

Vertex Pharmaceuticals, Danaher, United Therapeutics, argenex, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that research, develop, and commercialize therapies, drugs, diagnostics, and o...

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?

United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CPRX or UTHR: Which Is the Better Value Stock Right Now?

CPRX vs. UTHR: Which Stock Is the Better Value Option?

Equities Analysts Offer Predictions for UTHR FY2026 Earnings

United Therapeutics Corporation (NASDAQ:UTHR - Free Report) - Investment analysts at HC Wainwright lifted their FY2026 earnings estimates for shares of United Therapeutics in a note issued to...

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $581.63, for a total value of $5,525,485.00. Following the sale, the chief executive officer...

United Therapeutics (NASDAQ:UTHR) EVP Sells $4,696,721.00 in Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of the business's stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $565.87, for a total transaction of $4,696,721.00. Following the transaction, the executive...

United Therapeutics (NASDAQ:UTHR) CFO Sells $5,931,700.00 in Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 10,000 shares of the business's stock in a transaction dated Monday, March 30th. The stock was sold at an average price of $593.17, for a total transaction of $5,931,700.00. Following the transaction, the chief...

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,610,605.00 in Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of United Therapeutics stock in a transaction dated Monday, March 30th. The shares were sold at an average price of $590.59, for a total value of $5,610,605.00. Following the sale, the chief...

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

UTHR
United Therapeutics Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest UTHR News

UTHRUnited Therapeutics Corp